Summary
The product Dianabol Metandienone, manufactured by Vulkan Pharmaceuticals, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 1EY64P, was submitted by the manufacturer vulkanpharma@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Methandienone, with a concentration of 8.92 mg per unit, which is 10.8% below the standard expected dose of 10 mg per unit.
The testing process was conducted on 13 November 2024. While the results indicate a slight underdosing, scrutiny of manufacturer-submitted samples is essential to ensure reliability. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Vulkan Pharmaceuticals
- Product Name: Dianabol Metandienone
- Active Ingredient: Methandienone
- Batch Number: 1EY64P
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #52516
- Testing Ordered: 29 OCT 20244
- Sample Received: 05 NOV 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Vulkan Pharmaceuticals (Manufacturer)
- Analysis Paid For By: Vulkan Pharmaceuticals (Manufacturer)
Testing Results [H4]
- Specification: 10 mg per unit (standard expected dose)
- Measured Concentration: 8.92 mg per unit
- Accuracy: 89.2% (10.8% below the expected dose)
- Variance: -10.8%
Verification Details [H3]
- Verification URL: https://janoshik.com/tests/52516_4XT22F3HZMUE
Evaluation of Manufacturer-Submitted Testing [H3]
This analysis highlights a slight underdosing of the tested product, which warrants careful evaluation due to its submission by the manufacturer. Manufacturer-submitted samples may not always represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion [H3]
The analysis confirms that Dianabol Metandienone is slightly underdosed, with a measured concentration of 8.92 mg per unit. This result reflects a minor deviation from the expected dose and underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer [H3]
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
